Advisory Research’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-15,276
| Closed | -$2.55M | – | 341 |
|
|
2020
Q4 | $2.55M | Buy |
15,276
+3,444
| +29% | +$574K | 0.19% | 103 |
|
|
2020
Q3 | $1.83M | Sell |
11,832
-2,635
| -18% | -$407K | 0.18% | 110 |
|
|
2020
Q2 | $2.14M | Buy |
14,467
+1,204
| +9% | +$178K | 0.19% | 108 |
|
|
2020
Q1 | $1.49M | Sell |
13,263
-2,713
| -17% | -$306K | 0.1% | 105 |
|
|
2019
Q4 | $2.22M | Buy |
15,976
+2,218
| +16% | +$309K | 0.1% | 118 |
|
|
2019
Q3 | $1.33M | Sell |
13,758
-4,688
| -25% | -$451K | 0.06% | 155 |
|
|
2019
Q2 | $2.12M | Buy |
18,446
+2,172
| +13% | +$250K | 0.04% | 187 |
|
|
2019
Q1 | $1.92M | Sell |
16,274
-971
| -6% | -$114K | 0.04% | 191 |
|
|
2018
Q4 | $1.08M | Buy |
17,245
+5,412
| +46% | +$339K | 0.02% | 232 |
|
|
2018
Q3 | $838K | Buy |
+11,833
| New | +$838K | 0.01% | 270 |
|